Gardiquimod: A toll-like receptor-7 agonist that inhibits HIV type 1 infection of human macrophages and activated T cells

AIDS Research and Human Retroviruses

Volumn 29, Issue 6, 2013, Pages 907-918

  Buitendijk, Maarten ^a,b   Eszterhas, Susan K ^a,b   Howell, Alexandra L ^a,b  

^a VA MEDICAL CENTER   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA INTERFERON RECEPTOR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CD8 ANTIGEN; GARDIQUIMOD; MYELOID DIFFERENTIATION FACTOR 88; NEUTRALIZING ANTIBODY; RNA DIRECTED DNA POLYMERASE; UNCLASSIFIED DRUG;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; COCULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG INHIBITION; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LIFE CYCLE; MACROPHAGE; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN SECRETION; VIRUS REPLICATION;

AMINOQUINOLINES; ANTI-HIV AGENTS; CELL LINE; DNA, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; IMIDAZOLES; INTERFERON-ALPHA; LEUKOCYTES, MONONUCLEAR; MACROPHAGES; REAL-TIME POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 7; VIRUS REPLICATION;

EID: 84877852010     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2012.0313     Document Type: Article

References (50)

1. Kawai T and Akira S: The role of pattern-recognition receptors in innate immunity: Update on Toll-like receptors. Nat Immunol 2010;11(5):373-384
2. Akira S, Uematsu S, and Takeuchi O: Pathogen recognition and innate immunity. Cell 2006;124(4):783-801
3. Kawai T and Akira S: Innate immune recognition of viral infection. Nat Immunol 2006;7(2):131-137
4. Hornung V, Guenthner-Biller M, Bourquin C, et al.: Sequence-specific potent induction of IFN-Alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat Med 2005;11(3):263-270
5. Cros J, Cagnard N, Woollard K, et al.: Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity 2010;33(3):375-386
6. Douagi I, Gujer C, Sundling C, et al.: Human B cell responses to TLR ligands are differentially modulated by myeloid and plasmacytoid dendritic cells. J Immunol 2009;182(4):1991-2001
7. Caramalho I, Lopes-Carvalho T, Ostler D, Zelenay S, Haury M, and Demengeot J: Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med 2003;197(4):403-411
8. Song Y, Zhuang Y, Zhai S, et al.: Increased expression of TLR7 in CD8 (+) T cells leads to TLR7-mediated activation and accessory cell-dependent IFN-gamma production in HIV type 1 infection. AIDS Res Hum Retroviruses 2009; 25(12):1287-1295
9. Horsmans Y, Berg T, Desager JP, et al.: Isatoribine, an agonist of TLR7, reduces plasma virus concentration in chronic hepatitis C infection. Hepatology 2005;42(3):724-731
10. Wysocka M, Dawany N, Benoit B, et al.: Synergistic enhancement of cellular immune responses by the novel Toll receptor 7/8 agonist 3M-007 and interferon-gamma: Implications for therapy of cutaneous T-cell lymphoma. Leuk Lymphoma 2011;52(10):1970-1979
11. Gaspari AA: Mechanism of action and other potential roles of an immune response modifier. Cutis 2007;79(4 Suppl): 36-45
12. Hamilton MJ, Antignano F, von Rossum A, Boucher JL, Bennewith KL, and Krystal G: TLR agonists that induce IFNbeta abrogate resident macrophage suppression of T cells. J Immunol 2010;185(8):4545-4553
13. Liu YC, Gray RC, Hardy GA, et al.: CpG-B oligodeoxynucleotides inhibit TLR-dependent and -independent induction of type I IFN in dendritic cells. J Immunol 2010; 184(7):3367-3376
14. Rajagopal D, Paturel C, Morel Y, Uematsu S, Akira S, and Diebold SS: Plasmacytoid dendritic cell-derived type I interferon is crucial for the adjuvant activity of Toll-like receptor 7 agonists. Blood 2010;115(10):1949-1957
15. Lombardi V, Van Overtvelt L, Horiot S, and Moingeon P: Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of Il-10, IFN-gamma, and IL-17A by naive CD4 + T cells. J Immunol 2009;182(6):3372-3379
16. Brichacek B, Vanpouille C, Kiselyeva Y, et al.: Contrasting roles for TLR ligands in HIV-1 pathogenesis. PLoS One 2010;5(9
17. Wang Y, Abel K, Lantz K, Krieg AM, McChesney MB, and Miller CJ: The Toll-like receptor 7 (TLR7) agonist, imiquimod, and the TLR9 agonist, CpG ODN, induce antiviral cytokines and chemokines but do not prevent vaginal transmission of simian immunodeficiency virus when applied intravaginally to rhesus macaques. J Virol 2005;79(22): 14355-14370
18. Baenziger S, Heikenwalder M, Johansen P, et al.: Triggering TLR7 in mice induces immune activation and lymphoid system disruption, resembling HIV-mediated pathology. Blood 2009;113(2):377-388
19. Asin SN, Heimberg AM, Eszterhas SK, Rollenhagen C, and Howell AL: Estradiol and progesterone regulate HIV type 1 replication in peripheral blood cells. AIDS Res Hum Retroviruses 2008;24(5):701-716
20. Eszterhas S, Ilonzo N, Crozier J, Celaj S, and Howell A: Nanoparticles containing siRNA to silence CD4 and CCR5 reduce expression of these receptors and inhibit HIV-1 infection in human female reproductive tract tissue explants. Infectious Dis Rep 2011;3:52-61
21. Pereira CF, Boven LA, Middel J, Verhoef J, and Nottet HS: Induction of cyclooxygenase-2 expression during HIV-1-infected monocyte-derived macrophage and human brain microvascular endothelial cell interactions. J Leukoc Biol 2000;68(3):423-428
22. Kottilil S, Shin K, Planta M, et al.: Expression of chemokine and inhibitory receptors on natural killer cells: Effect of immune activation and HIV viremia. J Infect Dis 2004;189(7): 1193-1198
23. Giagulli C, Magiera AK, Bugatti A, et al.: HIV-1 matrix protein p17 binds to the IL-8 receptor CXCR1 and shows IL-8-like chemokine activity on monocytes through Rho/ ROCK activation. Blood 2012;119(10):2274-2283
24. Ross MJ, Fan C, Ross MD, et al.: HIV-1 infection initiates an inflammatory cascade in human renal tubular epithelial cells. J Acquir Immune Defic Syndr 2006;42(1):1-11
25. Lee C, Liu QH, Tomkowicz B, Yi Y, Freedman BD, and Collman RG: Macrophage activation through CCR5-And CXCR4-mediated gp120-elicited signaling pathways. J Leukoc Biol 2003;74(5):676-682
26. Peng H, Whitney N, Wu Y, et al.: HIV-1-infected and/or immune-Activated macrophage-secreted TNF-Alpha affects human fetal cortical neural progenitor cell proliferation and differentiation. Glia 2008;56(8):903-916
27. Roberts L, Passmore JA, Mlisana K, et al.: Genital tract inflammation during early HIV-1 infection predicts higher plasma viral load set point in women. J Infect Dis 2012; 205(2):194-203
28. Haase AT: Early events in sexual transmission of HIV and SIV and opportunities for interventions. Annu Rev Med 2011;62:127-139
29. Keele BF: Identifying and characterizing recently transmitted viruses. Curr Opin HIV AIDS 2010;5(4):327-334
30. Brenchley JM and Douek DC: HIV infection and the gastrointestinal immune system. Mucosal Immunol 2008;1(1): 23-30
31. Lehner T, Wang Y, Whittall T, and Seidl T: Innate immunity and HIV-1 infection. Adv Dent Res 2011;23(1):19-22
32. Shen R, Richter HE, and Smith PD: Early HIV-1 target cells in human vaginal and ectocervical mucosa. Am J Reprod Immunol 2011;65(3):261-267
33. Olsen JS, Easterhoff D, and Dewhurst S: Advances in HIV microbicide development. Future Med Chem 2011;3(16): 2101-2116
34. Lai WH, Huang L, and Chen CH: HIV entry inhibitors: Progress in development and application. Yao Xue Xue Bao 2010;45(2):131-140
35. Singh IP and Chauthe SK: Small molecule HIV entry inhibitors: Part II. Attachment and fusion inhibitors: 2004-2010. Expert Opin Ther Pat 2011;21(3):399-416
36. Singh IP and Chauthe SK: Small molecule HIV entry inhibitors: Part I. Chemokine receptor antagonists: 2004-2010. Expert Opin Ther Pat 2011;21(2):227-269
37. Teissier E, Penin F, and Pecheur EI: Targeting cell entry of enveloped viruses as an antiviral strategy. Molecules 2011; 16(1):221-250
38. Prajapati DG, Ramajayam R, Yadav MR, and Giridhar R: The search for potent, small molecule NNRTIs: A review. Bioorg Med Chem 2009;17(16):5744-5762
39. Li X, Krishnan L, Cherepanov P, and Engelman A: Structural biology of retroviral DNA integration. Virology 2011;411(2): 194-205
40. Debyser Z and Christ F: On the cell biology of HIV integration from basic research to development of novel antiviral drugs. Verh K Acad Geneeskd Belg 2010;72(5-6):219-237
41. Steuber H and Hilgenfeld R: Recent advances in targeting viral proteases for the discovery of novel antivirals. Curr Top Med Chem 2010;10(3):323-345
42. Jenwitheesuk E, Horst JA, Rivas KL, Van Voorhis WC, and Samudrala R: Novel paradigms for drug discovery: Computational multitarget screening. Trends Pharmacol Sci 2008;29(2):62-71
43. Bergamaschi A and Pancino G: Host hindrance to HIV-1 replication in monocytes and macrophages. Retrovirology 2010;7:31
44. Kedzierska K, Maerz A, Warby T, et al.: Granulocyte-macrophage colony-stimulating factor inhibits HIV-1 replication in monocyte-derived macrophages. AIDS 2000;14(12): 1739-1748
45. Thurman A and Doncel G: Innate immunity and inflammatory response to Trichomonas vaginalis and bacterial vaginosis: Relationship to HIV acquisition. Am J Reprod Immunol 2011;65(2):89-98
46. Appay V and Sauce D: Immune activation and inflammation in HIV-1 infection: Causes and consequences. J Pathol 2008;214(2):231-241
47. Meier A, Alter G, Frahm N, et al.: MyD88-dependent immune activation mediated by human immunodeficiency virus type 1-encoded Toll-like receptor ligands. J Virol 2007;81(15):8180-8191
48. Nian H, Geng WQ, Cui HL, et al.: R-848 triggers the expression of TLR7/8 and suppresses HIV replication in monocytes. BMC Infect Dis 2012;12:5
49. Schlaepfer E and Speck RF: Anti-HIV activity mediated by natural killer and CD8 + cells after toll-like receptor 7/8 triggering. PLoS One 2008;3(4):e1999
50. Fraietta JA, Mueller YM, Do DH, et al.: Phosphorothioate 2' deoxyribose oligomers as microbicides that inhibit human immunodeficiency virus type 1 (HIV-1) infection and block Toll-like receptor 7 (TLR7) and TLR9 triggering by HIV-1. Antimicrob Agents Chemother 2010;54(10): 4064-4073